• Consensus Rating: Buy
  • Consensus Price Target: GBX 310
  • Forecasted Upside: 40.27%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 221
▲ +3 (1.38%)

This chart shows the closing price for UPR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Uniphar Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UPR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UPR

Analyst Price Target is GBX 310
▲ +40.27% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Uniphar in the last 3 months. The average price target is GBX 310, with a high forecast of GBX 310 and a low forecast of GBX 310. The average price target represents a 40.27% upside from the last price of GBX 221.

This chart shows the closing price for UPR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Uniphar.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/21/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/19/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/17/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/16/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/15/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/12/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/11/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/4/2024Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 310
3/22/2023Shore CapitalReiterated RatingBuy
8/2/2021Shore CapitalReiterated RatingBuy
7/20/2021Shore CapitalReiterated RatingBuy
5/12/2021Shore CapitalReiterated RatingBuy
3/2/2021Shore CapitalReiterated RatingBuy
(Data available from 9/11/2019 forward)

News Sentiment Rating

0.59 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/14/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/15/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/14/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/14/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/13/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/13/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/12/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/11/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Uniphar logo
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers. The Pharma division provides high value services across the lifecycle of a pharmaceutical product; and healthcare professionals with access to medicines it cannot source through traditional channels, as well as operates its on demand and pharma service units. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, outsourcing and resourcing, telecommunications support, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: GBX 221
Low: 214
High: 224

50 Day Range

MA: GBX 217.77
Low: 200
High: 232

52 Week Range

Now: GBX 221
Low: 178
High: 256

Volume

140 shs

Average Volume

40,079 shs

Market Capitalization

£603.37 million

P/E Ratio

1,578.57

Dividend Yield

0.72%

Beta

0.75

Frequently Asked Questions

What sell-side analysts currently cover shares of Uniphar?

The following Wall Street analysts have issued research reports on Uniphar in the last twelve months: Deutsche Bank Aktiengesellschaft.
View the latest analyst ratings for UPR.

What is the current price target for Uniphar?

1 Wall Street analysts have set twelve-month price targets for Uniphar in the last year. Their average twelve-month price target is GBX 310, suggesting a possible upside of 40.3%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting UPR will reach GBX 310 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of GBX 310 for Uniphar in the next year.
View the latest price targets for UPR.

What is the current consensus analyst rating for Uniphar?

Uniphar currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe UPR will outperform the market and that investors should add to their positions of Uniphar.
View the latest ratings for UPR.

What other companies compete with Uniphar?

How do I contact Uniphar's investor relations team?

Uniphar's physical mailing address is 4045 Kingswood Road, Citywest Business Park, Dublin D24 V06K, Ireland. The company's listed phone number is 353 1 428 7777. The official website for Uniphar is www.uniphar.ie. Learn More about contacing Uniphar investor relations.